Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Filtration through the kidney eliminates toxins, manages electrolyte balance, and controls water homeostasis. Reabsorption of water from the luminal fluid of the nephron occurs through aquaporin-2 (AQP2) water pores in principal cells that line the kidney-collecting duct. This vital process is impeded by formation of an "actin barrier" that obstructs the passive transit of AQP2 to the plasma membrane. Bidirectional control of AQP2 trafficking is managed by hormones and signaling enzymes. We have discovered that
vasopressin
-independent facets of this homeostatic mechanism are under the control of A-Kinase Anchoring Protein 220 (
AKAP220
; product of the Akap11 gene). CRISPR/Cas9 gene editing and imaging approaches show that loss of
AKAP220
disrupts apical actin networks in organoid cultures. Similar defects are evident in tissue sections from
AKAP220
-KO mice. Biochemical analysis of
AKAP220
-null kidney extracts detected reduced levels of active RhoA GTPase, a well-known modulator of the actin cytoskeleton. Fluorescent imaging of kidney sections from these genetically modified mice revealed that RhoA and AQP2 accumulate at the apical surface of the collecting duct. Consequently, these animals are unable to appropriately dilute urine in response to overhydration. We propose that membrane-proximal signaling complexes constrained by
AKAP220
impact the actin barrier dynamics and AQP2 trafficking to ensure water homeostasis.
...
PMID:AKAP220 manages apical actin networks that coordinate aquaporin-2 location and renal water reabsorption. 2747 92